Literature DB >> 18426080

The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.

Kinya Okamoto1, Mari Mandai, Kenichi Mimura, Yoshikazu Murawaki, Isao Yuasa.   

Abstract

BACKGROUND/AIMS: Matrix metalloproteinases (MMPs) play important roles in cancer invasion and metastasis. Recently, functional gene polymorphisms in the promoter regions of MMP-1 1G/2G, MMP-3 5A/6A and MMP-9 C/T have been found, and have been reported to be associated with the prognosis of various cancers. In this study, we examined the association of the MMP-1, -3, -9 genotypes with the prognosis of hepatocellular carcinoma (HCC).
METHODS: Ninety two patients with hepatitis C virus related HCC were enrolled in the study. Genomic DNA samples were extracted from peripheral white blood cells, and gene polymorphisms of MMP-1, MMP-3and MMP-9 were analyzed by PCR-RFLP methods.
RESULTS: There were no significant differences of the survival rate between MMP-1 1G carriers and 2G homozygotes, and between MMP-9 T carriers and C homozygotes. By contrast, HCC patients with MMP-35A allele had a significantly poorer prognosis than 6A homozygotes.
CONCLUSIONS: Unlike MMP-1 and MMP-9 genotypes, MMP-3 5A allele, with higher transcriptional activity, may be a risk factor for the poor prognosis of HCC patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18426080

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  8 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

2.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

3.  The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.

Authors:  Yi-Liang Lai; Chi-Li Gong; Chun-Kai Fu; Te-Cheng Yueh; Chia-Wen Tsai; Wen-Shin Chang; Chieh-Lun Hsiao; Shiou-Ting Yen; Hsin-Ting Li; Long-Bin Jeng; Shou-Cheng Wang; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2017 Mar-Apr       Impact factor: 4.069

Review 4.  Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

Authors:  Khanh vinh quốc Lương; Lan Thi Hoàng Nguyễn
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

5.  Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle.

Authors:  Patricia S Diaz; Paula A Solar; Natalia E Juica; Pedro A Orihuela; Hugo Cardenas; Myron Christodoulides; Renato Vargas; Luis A Velasquez
Journal:  Reprod Biol Endocrinol       Date:  2012-08-16       Impact factor: 5.211

6.  Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.

Authors:  Xin Yang; Jing-Wen Hu; Man-Tang Qiu; Ming Li; Rong Yin; Jie Wang; Lin Xu; Qin Zhang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

7.  Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.

Authors:  Alicja Bauer; Andrzej Habior
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 8.  Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases.

Authors:  Eline Geervliet; Ruchi Bansal
Journal:  Cells       Date:  2020-05-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.